Open Access Open Access  Restricted Access Subscription Access

The Unified Etiology of Aging and Cancer: Cellular Damage and the Dual Role of Senescence

Shantanu Thakur, Baby llma

Abstract


Aging, broadly defined as the progressive decline in physiological function over time, is recognized as the strongest risk factor for a wide range of diseases. Once viewed as a natural curiosity, it is now the subject of rigorous scientific investigation aimed at disentangling its molecular and cellular underpinnings. A growing conceptual framework parallels the trajectory of cancer biology, suggesting that aging and cancer represent distinct outcomes of a common process the cumulative burden of cellular damage. Genomic instability, telomere erosion, and oxidative stress trigger adaptive mechanisms designed to preserve tissue integrity. While initially protective, these responses often deteriorate or persist in maladaptive forms, ultimately driving pathology. Central to this is cellular senescence, a state of irreversible growth arrest that prevents malignant transformation but, with age, contributes to tissue dysfunction. Beyond senescence, interconnected processes such as autophagy and regulation by non-coding RNAs orchestrate cellular responses to stress and damage, influencing both repair and degeneration. Viewing organismal decline and uncontrolled cell proliferation as outcomes of a unified damage-response network provides a holistic perspective on age-related disease. This paradigm not only deepens our understanding of the biology of aging but also highlights therapeutic avenues aimed at extending health span while mitigating cancer risk.

Full Text:

PDF

References


Brenner, S. (1973). The genetics of Caenorhabditis elegans. Mechanisms of Ageing and Development, 2(1), 65–80. https://doi.org/10.1016/0047-6374(73)90021-3

Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer.

Cell, 100(1), 57–70. https://doi.org/10.1016/S0092-8674(00)81683-9

Collado, M., & Serrano, M. (2008). Senescence in tumours: Evidence from mice and humans. Cell Cycle, 7(21), 2833–2839. https://doi.org/10.4161/cc.7.21.6965

López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer,

G. (2013). The hallmarks of aging. Cell, 153(6), 1194–1217. https://doi.org/10.1016/j.arr.2012.02.001

Ding, S. L., & Shen, C. Y. (2008). Model of human aging: Werner syndrome. Mechanisms of Ageing and Development, 129(5), 382–390. https://doi.org/10.1038/nrm2944

Campisi, J. (2013). Aging, cellular senescence, and cancer. Annual Review of Physiology, 75, 685–705. https://doi.org/10.1038/nrm2944

Shay, J. W., & Wright, W. E. (2019). Senescence and immortalization: Role of telomeres and telomerase. Nature Reviews Molecular Cell Biology, 20(9), 543–554. https://doi.org/10.1038/s41580-020-00314-w

Collado, M., Blasco, M. A., & Serrano, M. (2007). Cellular senescence in cancer and aging. Nature Reviews Cancer, 7(6), 451–

https://doi.org/10.1038/nrc2393

Campisi, J. (2005). Suppressing cancer: The importance of being senescent. Nature Reviews Molecular Cell Biology, 6(9), 729–739. https://doi.org/10.1038/nrm1987

Muñoz-Espín, D., & Serrano, M. (2014). Cellular senescence: From physiology to pathology. Nature Reviews Cancer, 14(7), 482–496. https://doi.org/10.1038/nrc3960


Refbacks

  • There are currently no refbacks.